Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Nov 12 2024
Business
Nov 12 2024
5 min read

Press Release Nov 12 2024

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 12, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Ivabradine Tablets, 5 mg and 7.5 mg".

View Attachment